FHTXNasdaq

Foghorn Therapeutics Inc.

Pharmaceutical Preparations · DE · CIK 1822462

Foghorn Therapeutics pioneers precision medicines by targeting the chromatin regulatory system to correct abnormal gene expression in serious diseases

+ Watch View on EDGAR ↗

$245M

Market cap

$4.86

Last close

+15.2%

+16.3%

389K

Volume

Price · last 39 sessions+3.8%

May 4L $3.60 · H $4.86Jun 29

140

Total filings

Jun 24, 2026

Last filing

12/31

Fiscal year end

All 8-K · 87 10-Q · 17 10-K · 6 DEF 14A · 6 424B5 · 5 SC 13G · 5 DEFA14A · 5 S-1/A · 2

SC 13GSC 13GSep 20, 2024 SC 13GTHE SCHEDULE 13GMay 30, 2024 SC 13GSC 13GApr 19, 2021 SC 13GSC 13GFeb 8, 2021 SC 13GSCHEDULE 13GFeb 4, 2021

Similar companies

Comparable business profile · signals at a glance

CCCCC4 Therapeutics, Inc.$431.2M+2.1%CAMPCamp4 Therapeutics Corp$217.6M+5.7%BCAXBicara Therapeutics Inc.$1.4B+9.2%KYMRKymera Therapeutics, Inc.$7.1B+1.1%ARVNARVINAS, INC.